- Home
- SENS vs SOPH Comparison
SENS vs SOPH Comparison
Compare SENS & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENS
- SOPH
- Stock Information
- Founded
- SENS 1996
- SOPH 2011
- Country
- SENS United States
- SOPH Switzerland
- Employees
- SENS N/A
- SOPH N/A
- Industry
- SENS Industrial Machinery/Components
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SENS Industrials
- SOPH Health Care
- Exchange
- SENS Nasdaq
- SOPH Nasdaq
- Market Cap
- SENS 255.8M
- SOPH 231.8M
- IPO Year
- SENS N/A
- SOPH 2021
- Fundamental
- Price
- SENS $6.01
- SOPH $4.12
- Analyst Decision
- SENS Strong Buy
- SOPH Strong Buy
- Analyst Count
- SENS 6
- SOPH 1
- Target Price
- SENS $25.58
- SOPH $7.00
- AVG Volume (30 Days)
- SENS 537.3K
- SOPH 118.2K
- Earning Date
- SENS 11-05-2025
- SOPH 11-04-2025
- Dividend Yield
- SENS N/A
- SOPH N/A
- EPS Growth
- SENS N/A
- SOPH N/A
- EPS
- SENS N/A
- SOPH N/A
- Revenue
- SENS $29,298,000.00
- SOPH $73,297,000.00
- Revenue This Year
- SENS $63.07
- SOPH $16.60
- Revenue Next Year
- SENS $73.56
- SOPH $19.09
- P/E Ratio
- SENS N/A
- SOPH N/A
- Revenue Growth
- SENS 31.94
- SOPH 13.66
- 52 Week Low
- SENS $5.00
- SOPH $2.58
- 52 Week High
- SENS $28.00
- SOPH $5.30
- Technical
- Relative Strength Index (RSI)
- SENS 57.74
- SOPH 44.39
- Support Level
- SENS $5.51
- SOPH $4.21
- Resistance Level
- SENS $6.59
- SOPH $4.70
- Average True Range (ATR)
- SENS 0.45
- SOPH 0.34
- MACD
- SENS -0.31
- SOPH -0.08
- Stochastic Oscillator
- SENS 27.19
- SOPH 6.20
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.